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OBJECTIVES: To evaluate the Rochester and modified Philadelphia criteria for the risk

stratification of febrile infants with invasive bacterial infection (IBI) who do not appear ill
without routine cerebrospinal fluid (CSF) testing.

abstract

METHODS: We performed a case-control study of febrile infants ≤60 days old presenting to 1
of 9 emergency departments from 2011 to 2016. For each infant with IBI (defined as a blood
[bacteremia] and/or CSF [bacterial meningitis] culture with growth of a pathogen), controls
without IBI were matched by site and date of visit. Infants were excluded if they appeared
ill or had a complex chronic condition or if data for any component of the Rochester or
modified Philadelphia criteria were missing.
RESULTS: Overall, 135 infants with IBI (118 [87.4%] with bacteremia without meningitis and

17 [12.6%] with bacterial meningitis) and 249 controls were included. The sensitivity of
the modified Philadelphia criteria was higher than that of the Rochester criteria (91.9% vs
81.5%; P = .01), but the specificity was lower (34.5% vs 59.8%; P < .001). Among 67 infants
>28 days old with IBI, the sensitivity of both criteria was 83.6%; none of the 11 low-risk
infants had bacterial meningitis. Of 68 infants ≤28 days old with IBI, 14 (20.6%) were low
risk per the Rochester criteria, and 2 had meningitis.

CONCLUSIONS: The modified Philadelphia criteria had high sensitivity for IBI without routine

CSF testing, and all infants >28 days old with bacterial meningitis were classified as high
risk. Because some infants with bacteremia were classified as low risk, infants discharged
from the emergency department without CSF testing require close follow-up.
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WHAT’S KNOWN ON THIS SUBJECT: The Rochester and
modified Philadelphia criteria do not include routine
cerebrospinal fluid testing. Although these criteria have
high sensitivity in the risk stratification of febrile infants
with serious bacterial infections, most studies had few
infants with bacteremia and/or bacterial meningitis.
WHAT THIS STUDY ADDS: The modified Philadelphia
criteria were highly sensitive in the risk stratification of
non–ill-appearing febrile infants with bacteremia, and
no infants with bacterial meningitis were classified as
low risk. Two infants ≤28 days old with meningitis were
classified as low risk by the Rochester criteria.
To cite: Aronson PL, Wang ME, Shapiro ED, et al. Risk
Stratification of Febrile Infants ≤60 Days Old Without Routine
Lumbar Puncture. Pediatrics. 2018;142(6):e20181879
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ARTICLE

Approximately 10% of febrile
infants ≤60 days of age evaluated
in the emergency department (ED)
have a serious bacterial infection.1
To identify infants who may be
discharged from the ED after initial
evaluation, the Rochester and
Philadelphia criteria2– 4 are widely
used to stratify febrile infants on
the basis of their risk of serious
bacterial infection.5 Although these
criteria have a reported sensitivity
of >90% in the risk stratification of
febrile infants with serious bacterial
infections, these studies included
mostly infants with urinary tract
infections (UTIs), with relatively
few infants with bacteremia and/
or bacterial meningitis4 (ie, invasive
bacterial infection [IBI]). Therefore,
data are limited regarding the
precision of the Rochester and
Philadelphia criteria in the risk
stratification of infants with IBI.4
Additionally, with a changing
epidemiology of IBI in febrile
infants since the development of
these criteria >2 decades ago,6,7 the
performance of these criteria needs
to be reevaluated periodically.4,8

Given the rarity of bacterial
meningitis in febrile infants >28
days of age who appear well and
the unclear benefit of routine
cerebrospinal fluid (CSF) testing,9– 11

some providers do not automatically
perform CSF testing in this age group,
although practice varies substantially
across hospitals.12,13 The Rochester
criteria and the modified
Philadelphia criteria do not require
routine CSF testing to classify febrile
infants as being at a low or high risk
for serious bacterial infection.2,9
Data regarding the performance
characteristics of the Rochester and
modified Philadelphia criteria in a
large sample of febrile infants ≤60
days of age with IBI would inform
the need for routine CSF testing in
this population. Our objective was to
evaluate the Rochester and modified
Philadelphia criteria for the risk
stratification of infants with IBI using
2

a contemporary sample of febrile
infants ≤60 days of age evaluated in
the ED.

METHODS
Study Design
We analyzed data collected for a casecontrol study of febrile infants ≤60
days of age evaluated in the ED at 1
of 11 children’s hospitals between
July 1, 2011, and June 30, 2016. The
current study was limited to the 9
hospitals containing hematology
laboratories that reported band
counts because these were included
in both the Rochester criteria and
the modified Philadelphia criteria.
The study was approved by each
site’s institutional review board with
permission for data sharing.

Cases

Infants ≤60 days of age with IBI were
identified through query of each
hospital’s microbiology laboratory
database or electronic medical record
system for blood and/or CSF cultures
positive for a pathogen (defined a
priori).7 Infants were excluded if
the culture with positive results
was documented in the medical
record to have been treated as a
contaminant.7,14,
 15
 Bacteremia was
defined as growth of a pathogen in
a blood culture. Bacterial meningitis
was defined as growth of a pathogen
in a CSF culture (with or without
bacteremia) or growth of a pathogen
in a blood culture with concomitant
CSF pleocytosis if antimicrobial
agents were administered before
CSF collection. CSF pleocytosis was
defined as a CSF white blood cell
(WBC) count of ≥20 cells per mm3 for
infants ≤28 days of age and ≥10 cells
per mm3 for infants 29 to 60 days of
age.16
Infants with IBI were included as
case patients if they presented either
from home or from an outpatient
clinic to the participating hospital’s
ED (ie, were not transferred
from another hospital) and if the

following criteria were met: (1)
presence of fever (defined as a rectal
temperature of ≥38.0°C at home, in
an outpatient clinic, or in the ED4),
(2) no ill appearance as documented
on the ED physical examination,17
and (3) absence of a complex chronic
condition.18,19
 For all infants with
IBI, medical records in the 30 days
after were reviewed to assess for a
diagnosis of bacterial meningitis.

Controls

Each case patient was matched by
hospital and date of visit to 2 febrile
infant controls. Potentially eligible
controls were identified through
a query of the Pediatric Health
Information System database for
infants ≤60 days of age with an ED
visit to a participating hospital during
the 5-year study period and who had
urine and blood cultures obtained.
A query of the electronic medical
record system was performed at 1
site that did not contribute ED data
to the Pediatric Health Information
System. For each case patient at
a participating site, infants with
the closest date of visit to the case
patient were selected as potential
controls; if >2 infants were eligible on
the basis of visit proximity, a random
number generator was used to select
which controls to include.

Medical records were reviewed for
each potential control to determine
the presence of fever and to confirm
eligibility. Controls were eligible if (1)
they met the same inclusion criteria
as case patients, (2) their blood and/
or CSF culture did not have growth
of a pathogen, and (3) they had not
received antibiotics within 7 days
before the ED visit. For all controls,
medical records for the 30 days
after the ED visit were reviewed
to ensure that the infant was not
diagnosed with an IBI. If a potentially
eligible control was determined to
be ineligible after a medical record
review, an infant with the next
closest date of visit was selected, with
the process repeated until an eligible
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TABLE 1 Low-Risk Components for the Rochester and Modified Philadelphia Criteria
Components
Demographics
Past medical history
Physical examination
Laboratory

Rochester
N/Aa
Previously healthyb
No skin or soft tissue infection
Normal urinalysisc; peripheral WBC count of ≥5000 and ≤15 000;
absolute band count of ≤1500 bands per μL

Modified Philadelphia
Age >28 d
Previously healthyb
No skin or soft tissue infection
Normal urinalysisc; peripheral WBC count of ≥5000 and
≤15 000; I/T ratio of <0.2d

N/A, not applicable.
a Rochester criteria include infants ≤60 d of age without an age cutoff to define low risk.
b Gestational age ≥37 wk; no previous ED visit, hospitalization, or evaluation for fever; no previous IBI or treatment with antibiotics; no other significant past medical history.
c Urine dipstick with no or trace leukocyte esterase, negative nitrites, and urine microscopy, with ≤5 WBCs per HPF or ≤5 WBCs per mm3 on an enhanced urinalysis.
d Bands-to-total neutrophil ratio.

control was identified. Febrile infants
with UTIs7,20,21 but without IBI were
eligible for inclusion as controls.

Data Collection

For each case patient and control,
we extracted the following data:
demographics (age and sex);
past medical history (including
gestational age); clinical appearance
and presence of a localized infection;
complete blood count, urinalysis,
and CSF cell count; and bacterial
culture results (urine, blood, and
CSF). Study investigators at each site
entered data into a secure Research
Electronic Data Capture tool hosted
at Yale University.22

Rochester and Modified Philadelphia
Criteria
 able 1 lists the components
T
of the Rochester and modified
Philadelphia criteria that classified
an infant as low risk.9,23
 For both
criteria, the definition of a normal
urinalysis was based on currently
used urine dipstick and microscopy
parameters.20 Band counts require
performance of a manual differential
on a complete blood count. Because
performance of a manual differential
is usually reflexively triggered
by specific parameters set on a
hospital’s automated hematology
analyzer,24 the band count was
recorded as 0 if only an automated
differential was performed, and
no bands were reported. The
immature-to-total (I/T) neutrophil
ratio was defined as the percentage
of bands divided by the percentage
of total neutrophils on a complete

blood count. Infants were excluded
from the primary analyses if data
were missing for any component
of the Rochester or modified
Philadelphia criteria (eg, gestational
age, urinalysis, or peripheral WBC
count).23

Statistical Analyses

Categorical variables were
described by using frequencies and
percentages, and distributions were
compared by using a χ2 test. For the
Rochester and modified Philadelphia
criteria, sensitivity and specificity
were calculated and reported with
95% confidence intervals (CIs).
Because both the Rochester and
Philadelphia criteria have historically
used ≤10 WBCs per high-power field
(HPF) or ≤10 WBCs per mm3 on an
enhanced urinalysis2,9,
 23
 to define
a normal urinalysis, analyses were
repeated by using this definition.
Additionally, because the modified
Philadelphia criteria were developed
for infants ≤56 days of age,9 analyses
were repeated after limiting the
sample to infants in this age range.
Because of concerns regarding the
introduction of bias on the basis of
the exclusion of infants with IBI, we
also calculated the sensitivity of the
Rochester and modified Philadelphia
criteria after the inclusion of infants
with missing data.
Statistical analyses were performed
by using Stata data analysis and
statistical software version 15.0
(Stata Corp, College Station, TX). A
2-tailed P value < .05 was considered
statistically significant.

RESULTS
Study Sample
During the 5-year study period, 331
infants with IBI were evaluated in the
EDs of the 9 participating hospitals.
Eighty-six infants (26.0%) were
excluded because of ill appearance,
including 26 febrile infants who had
bacterial meningitis. Of the infants
with IBI who did not appear ill,
145 met inclusion criteria as case
patients and were matched to 290
controls. Because of missing data on
clinical or laboratory components
of the Rochester and/or modified
Philadelphia criteria, 10 case patients
and 41 controls were excluded,
resulting in a final study sample of
135 case patients and 249 controls
(Fig 1). Among the 135 infants with
IBI, 118 (87.4%) had bacteremia
without meningitis, and 17 (12.6%)
had bacterial meningitis (with or
without bacteremia). Of the 17
infants with bacterial meningitis, 7
(41.2%) were >28 days of age.

Sensitivity and Specificity of the
Rochester and Modified Philadelphia
Criteria
A higher proportion of febrile infants
with IBI were ≤28 days of age and
had abnormal laboratory parameters
compared with matched controls
(Table 2). Sixty-one infants with IBI
(45.2%) had a UTI compared with 15
controls (6.0%). Overall, 25 infants
with IBI (18.5%; 95% CI: 12.4%–
26.1%) were classified as low risk
per the Rochester criteria compared
with 11 infants (8.1%; 4.1%–14.1%)
who were classified as low risk
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was not materially different (91.7%
overall and 83.1% among infants
29–60 days of age).

Febrile Infants With IBI Classified as
Low Risk
Of the 11 infants with IBI classified
as low risk per the modified
Philadelphia criteria, none were
diagnosed with bacterial meningitis
(Table 4). Two of these infants had
mild CSF pleocytosis after traumatic
lumbar punctures, and neither
received an antimicrobial treatment
course for bacterial meningitis. The
additional 14 infants with IBI who
were classified as low risk per the
Rochester criteria were all ≤28
days of age, including 2 infants with
bacterial meningitis (Table 4). Both
of these infants (≤28 days of age
with bacterial meningitis) would
have been classified as high risk per
the modified Philadelphia criteria
because of an I/T ratio of ≥0.2.

FIGURE 1

Study population. a One infant was missing a urinalysis and complete blood count.

per the modified Philadelphia
criteria (difference: 10.4%; 95% CI:
2.2%–18.6%).

The sensitivity of the Rochester
criteria was lower than the sensitivity
of the modified Philadelphia criteria
(81.5% vs 91.9%; P = .01), but
the specificity was higher (59.8%
vs 34.5%; P < .001). The criteria
performed similarly when restricted
to infants 29 to 60 days of age (Table
3). Additionally, performance of the
modified Philadelphia criteria was
similar when limited to infants ≤56
days of age. By using the historical
definition of ≤10 WBCs per HPF
or ≤10 WBCs per mm3 to define a
normal urinalysis, the sensitivities
4

of both the Rochester and modified
Philadelphia criteria were lower
(74.8% and 88.2%, respectively),
with a marginal increase in specificity
(63.5% and 36.1%).
With the inclusion of the 10 infants
with IBI who had missing data, an
additional 4 infants were classified
as low risk by the Rochester criteria,
including 1 infant who was also
classified as low risk per the modified
Philadelphia criteria. When including
these infants in the analysis, the
sensitivity of the Rochester criteria
was slightly lower overall (80.0%)
and among infants 29 to 60 days of
age (81.7%), whereas the sensitivity
of the modified Philadelphia criteria

Of the 4 infants with IBI who had
missing data and were classified as
low risk per the Rochester criteria,
2 infants (ages 13 and 40 days) had
group B streptococcal meningitis;
both infants had a missing urinalysis.
The 40-day-old infant had a
peripheral WBC count of 15 000 cells
per μL and an absolute band count of
1200 bands per μL, with an I/T ratio
of 0.2. The 1 infant classified as low
risk per the modified Philadelphia
criteria was a 55-day-old infant with
group B streptococcal bacteremia
and mild CSF pleocytosis after a
traumatic lumbar puncture; the
infant was not treated for bacterial
meningitis.

DISCUSSION
In this validation study that included
a large multicenter sample of febrile
infants with IBI who did not appear
ill, the modified Philadelphia criteria
were highly sensitive in the risk
stratification of infants with IBI.
Importantly, no infants with bacterial
meningitis were classified as low
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TABLE 2 Characteristics of Case Patients and Controls
Characteristic
Demographics
Age group, d
  ≤28
  29–60
Female sex
Parameters of Rochester criteria
Low risk
  Previously healthya
  Normal urinalysisb
  Peripheral WBC ≥5000 and ≤15 000
  Normal absolute band countc
Parameters of modified Philadelphia criteria
Low risk
  Previously healthya
  Normal urinalysisb
  Peripheral WBC ≥5000 and ≤15 000
  Normal I/T ratiod

Case Patients (N = 135), n (%)

Controls (N = 249), n (%)

68 (50.4)
67 (49.6)
61 (45.2)

92 (37.0)
157 (63.1)
102 (41.0)

.42

25 (18.5)
107 (79.3)
61 (45.2)
86 (63.7)
110 (81.5)

149 (59.8)
206 (82.7)
219 (88.0)
200 (80.3)
240 (96.4)

<.001
.40
<.001
<.001
<.001

11 (8.1)
107 (79.3)
61 (45.2)
86 (63.7)
103 (76.3)

86 (34.5)
206 (82.7)
219 (88.0)
200 (80.3)
234 (94.0)

<.001
.40
<.001
<.001
<.001

P
.01

Gestational age ≥37 wk; no previous ED visit, hospitalization, or evaluation for fever; no previous IBI or treatment with antibiotics; no other significant past medical history.
Urine dipstick with no or trace leukocyte esterase, negative nitrites, and urine microscopy, with ≤5 WBCs per HPF or ≤5 WBCs per mm3 on an enhanced urinalysis.
c Absolute band count ≤1500.
d Bands-to-total neutrophil ratio <0.2.
a

b

TABLE 3 Performance Characteristics of the Rochester and Modified Philadelphia Criteria for the Identification of IBI in Febrile Infants
Infants ≤60 d of age
Rochester criteria
Modified Philadelphia criteria
Infants ≤28 d of age
Rochester criteria
Modified Philadelphia criteriaa
Infants 29–60 d of age
Rochester criteria
Modified Philadelphia criteria
a

Sensitivity (95% CI)

Specificity (95% CI)

81.5 (73.9–87.6)
91.9 (85.9–95.9)

59.8 (53.5–66.0)
34.5 (28.6–40.8)

79.4 (67.9–88.3)
100 (94.7–100)

64.1 (53.5–73.9)
0 (0–3.9)

83.6 (72.5–91.5)
83.6 (72.5–91.5)

57.3 (49.2–65.2)
54.8 (46.6–62.7)

All infants ≤28 d of age were considered high risk per the modified Philadelphia criteria.

risk. Although the Rochester criteria
had a similar sensitivity for IBI in
febrile infants >28 days of age, 2
infants ≤28 days of age with bacterial
meningitis were classified as low
risk. Our findings support the use of
the modified Philadelphia criteria
without routine CSF testing for
febrile infants in the second month
of life.

Although only 0.2% of febrile infants
29 to 60 days of age who present to
the ED have bacterial meningitis,6
many pediatric emergency medicine
clinicians routinely perform CSF
testing in this age group because of
the high rate of neurologic sequelae
and mortality associated with this
condition.25,26
 However, performance
of routine CSF testing in this age
group is associated with higher

costs, increased hospitalization
rates for otherwise low-risk infants,
and significant stress for parents,
all without a reduction in adverse
outcomes compared with selective
CSF testing.10,13,27,
 28
 Therefore,
some have questioned the need for
routine CSF testing in this age group.
However, previous investigations in
which the Rochester and modified
Philadelphia criteria were evaluated
included few infants with bacterial
meningitis who did not appear
ill.4,8,
 9,23


Our results inform this important
issue by revealing that the modified
Philadelphia criteria had high
sensitivity for IBI and classified all
infants with bacterial meningitis as
high risk without routine CSF testing.
Although 11 infants 29 to 60 days

of age were classified as low risk by
the modified Philadelphia criteria, all
the infants had bacteremia without
meningitis, and the 2 infants with
CSF pleocytosis had traumatic
lumbar punctures. Additionally,
we excluded 26 febrile infants with
bacterial meningitis who appeared
ill, all of whom would have been
classified as high risk by the modified
Philadelphia criteria because of their
ill appearance.9

The overall prevalence of IBI has
been reported to be 2% in febrile
infants.6 Therefore, among the
thousands of febrile infants evaluated
in the ED, few infants with IBI will
be missed with use of these criteria.
For instance, of 300 febrile infants
>28 days of age who do not appear
ill, 6 (2%) will have an IBI, and 1 of
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ageb

7.6
11.2
9.6

Not performedc
0–5
Not performedc
0.25
0
0.12
0.20
0
0
0
0.02
0
0
0
0
0
0.10
0
0
0.15
0

11.8
9.1
11.4
7.2
9.6
14.7
11.4
6.5
9.4
10.4
9.6
6.7
11.1
8.1

0–5
0–5
Not performedc

0–5
0–5
0–5
Not performedc
0–5
0–5
0–5
0–5
0–5
0–5
0–5

0
0
0

0
0.10
0.02
0.15

I/T Ratioa

6.9
10.3
9.2
6.7

0–5
0–5
0–5
0–5

8.6
9.5
10.6
13.0

Peripheral WBC

0–5
0–5
0–5
0–5

Urinalysis WBC

GBS, group B Streptococcus; RBC, red blood cell.
a Bands-to-total neutrophil ratio.
b Low risk per the Rochester criteria only.
c Urine dipstick with negative leukocyte esterase and negative nitrites.
d Low risk per the Rochester and modified Philadelphia criteria.

24
24
28
Infants 29–60 d of aged
29
29
38
40
41
47
50
50
53
55
60

18
19
19
22

13
17
18

Infants ≤28 d of
3
4
10
11

Age, d

72
0
0
0
0
0
830
0
0
1221
0

0
0
0

1035
0
644
1146

0
0
0

0
760
212
1404

Absolute Band Count

Not obtained
20
2
0
4
1
1
4
4
80
1

6
120
0

1385
5
3
1024

31
Not obtained
9

35
10
16
198

CSF WBC Count

TABLE 4 Febrile Infants With IBI Classified as Low Risk per the Rochester and Modified Philadelphia Criteria

Not obtained
28 000
0
6750
0
1
13
1
36
55 590
0

738
2585
81 500

16
88
4
46 305

29 590
Not obtained
4010

3180
7150
13
273 000

CSF RBC Count

No growth
No growth
No growth
No growth
No growth
No growth
No growth
No growth
Contaminant
No growth
No growth

No growth
No growth
No growth

No growth
Klebsiella oxytoca
No growth
Contaminant

No growth
No growth
No growth

No growth
No growth
No growth
No growth

Urine Culture

GBS
Salmonella spp
GBS
E faecalis
GBS
GBS
GBS
GBS
Salmonella spp
GBS
E coli

Enterococcus faecalis
Escherichia coli
GBS
Group A
Streptococcus
Klebsiella pneumoniae
Salmonella spp
Group A
Streptococcus
Paenibacillus
K oxytoca
GBS
Streptococcus
gallolyticus
GBS
GBS
Enterobacter

Blood Culture

No growth
No growth
No growth
No growth
No growth
No growth
No growth
No growth
No growth
No growth
No growth

No growth
No growth
No growth

Paenibacillus
No growth
No growth
S gallolyticus

No growth
No growth
No growth

No growth
No growth
No growth
No growth

CSF Culture

these 6 infants will be classified as
low risk by the modified Philadelphia
criteria. Therefore, only 1 of 300
febrile infants (0.3%) who do not
appear ill will have an IBI, specifically
with bacteremia, that will be missed
with use of these criteria. Although
the Rochester criteria had a similar
sensitivity for IBI among infants 29
to 60 days of age, when including
infants with missing data, 1
infant with bacterial meningitis in
this age group was classified as low
risk; our results favor the use of
the modified Philadelphia criteria.
However, ultimately, clinicians
must balance the rarity of bacterial
meningitis in febrile infants >28 days
of age who do not appear ill and the
risks of a lumbar puncture27,28

with the potential for serious
neurologic sequelae or death if
treatment is delayed.25,26 For infants
treated with empirical antimicrobial
therapy without performance of
CSF testing, there is potential for
prolonged antimicrobial therapy if
the blood culture grows a pathogen
and CSF pleocytosis is present on
a subsequent lumbar puncture.
Additionally, although infection with
herpes simplex virus is rare among
febrile infants >28 days age,29,30
 CSF
testing should be obtained in this
age group if herpes simplex virus is
suspected (eg, presence of vesicles or
seizures).31

The prevalence of IBI is highest
among febrile infants ≤28 days of
age, and 1% of these infants will have
bacterial meningitis.6 Although most
infants in the first month of life who
are classified as low risk without CSF
testing will not have an IBI, 2 infants
with meningitis in our study would
have been missed by the Rochester
criteria. Although a recently validated
procalcitonin-based, low-risk
algorithm that also does not include
routine CSF testing (the step-by-step
approach) uses an age cutoff of 21
days instead of 28 days,32 in our study,
3 infants with IBI, including 1 with
bacterial meningitis, were between

22 and 28 days of age and were
classified as low risk per the Rochester
criteria. Therefore, caution should be
exercised in applying these criteria to
febrile infants ≤28 days of age.

The sensitivity and specificity of
the modified Philadelphia criteria
were similar to those of the stepby-step approach.32 Because
procalcitonin is not currently
available at some US hospitals, the
modified Philadelphia criteria can
be more widely implemented for the
risk stratification of febrile infants.
However, these criteria should be
prospectively tested against the
step-by-step approach in a large
cohort of febrile infants. Additionally,
although favorable outcomes have
been reported for infants managed
as outpatients with the step-by-step
approach,33 future investigation is
needed to evaluate outcomes with
use of the modified Philadelphia
criteria.

Our study has several limitations.
First, data were collected through a
medical record review, and clinical
variables, such as clinical appearance,
may not be accurately documented.
However, we used a previously
utilized definition of ill appearance,
and we only included infants who
were not ill appearing.17 Second,
although our search strategy for
identifying case patients made it
unlikely that we missed infants with
IBI, we were unable to calculate the
positive and negative predictive
values of the Rochester and modified
Philadelphia criteria because we
did not include all febrile infants at
study sites. Third, only 17 infants in
our sample had bacterial meningitis,
reflecting the low prevalence of this
condition among infants who do
not appear ill. However, our study
included the largest sample to date
of febrile infants ≤60 days of age
with IBI who did not appear ill.
Additionally, although we excluded
26 infants with bacterial meningitis
who appeared ill, all of these infants
would have been classified as high

risk by both the Rochester and
modified Philadelphia criteria.9,23

Fourth, although we reviewed
subsequent visits for controls, we
cannot exclude the possibility that
a control was diagnosed with IBI at
a nonparticipating hospital. Fifth,
although we excluded infants with
IBI who had missing documentation
of any component of the Rochester
or modified Philadelphia criteria, we
included these infants in a sensitivity
analysis. Sixth, the band count was
recorded as 0 if only an automated
differential was performed on the
complete blood count, and no bands
were reported. Manual differentials
are triggered reflexively by a
hospital’s automated hematology
analyzer or on request from a
clinician. It is therefore possible that
some low-risk infants with IBI and
0 bands would have been classified
as high risk if a manual differential
had been performed, which may have
resulted in an underestimation of the
sensitivity of the criteria. Lastly, we
only included infants who presented
to EDs at participating children’s
hospitals, and our results may not
be generalizable to other settings,
particularly community-based EDs.

CONCLUSIONS

The modified Philadelphia criteria,
which does not include routine
CSF testing, classifies most febrile
infants with IBI as high risk. Because
a few infants >28 days of age with
bacteremia were classified as low
risk, febrile infants discharged from
the ED without CSF testing should
have close outpatient follow-up.
Caution should be exercised in
applying low risk criteria to infants
≤28 days of age. A prospective study
is needed to confirm the safety of
routinely omitting CSF testing in lowrisk febrile infants >28 days of age.

ACKNOWLEDGMENTS

We thank the following collaborators
in the Febrile Young Infant Research
Collaborative for their contributions

Downloaded from www.aappublications.org/news by guest on January 21, 2020
PEDIATRICS Volume 142, number 6, December 2018

7

as group authors for this study:
Elizabeth R. Alpern, MD, MSCE,
Northwestern University Feinberg
School of Medicine (Chicago,
IL); Whitney L. Browning, MD,
Vanderbilt University School of
Medicine (Nashville, TN); Elana
A. Feldman, MD, Lucile Packard
Children’s Hospital Stanford
(Palo Alto, CA); Katie L. Hayes, BS,
Children’s Hospital of Philadelphia
(Philadelphia, PA); Catherine E.

Lumb, BS, University of Alabama
School of Medicine (Birmingham,
AL); Christine E. Mitchell, BSN,
Children’s Hospital of Philadelphia
(Philadelphia, PA); Nipam Shah,
MBBS, MPH, University of Alabama
at Birmingham (Birmingham, AL);
Sarah J. Shin, BSN, Children’s Hospital
of Philadelphia (Philadelphia, PA);
and Derek J. Williams, MD, MPH,
Vanderbilt University School of
Medicine (Nashville, TN).

ABBREVIATIONS
CI: c onfidence interval
CSF: c erebrospinal fluid
ED: e mergency department
HPF: h
 igh-power field
IBI: invasive bacterial
infection
I/T: immature-to-total
UTI: urinary tract infection
WBC: white blood cell

Tennessee; and oDivision of Emergency Medicine, and pCenter for Pediatric Clinical Effectiveness, Children’s Hospital of Philadelphia and Department of Pediatrics, Perelman School of
Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

Dr Aronson conceptualized and designed the study, supervised data collection locally and nationally, performed the data analyses, interpreted the data,
drafted the initial manuscript, and reviewed and revised the manuscript critically for important intellectual content; Dr Wang contributed to the design of the
study, collected local data, interpreted the data, and reviewed and revised the manuscript critically for important intellectual content; Drs Shapiro and Shah
contributed to the design of the study, interpreted the data, and reviewed and revised the manuscript critically for important intellectual content; Drs DePorre,
McCulloh, Pruitt, Desai, Nigrovic, Marble, Leazer, Rooholamini, Sartori, Balamuth, and Woll collected local data, interpreted the data, and reviewed and revised the
manuscript critically for important intellectual content; Dr Neuman contributed to the conceptualization and design of the study, collected local data, interpreted
the data, and reviewed and revised the manuscript critically for important intellectual content; and all authors approved the final manuscript as submitted and
agree to be accountable for all aspects of the work.
Dr McCulloh’s current affiliation is Children’s Hospital and Medical Center, Omaha, NE.
DOI: https://doi.org/10.1542/peds.2018-1879
Accepted for publication Sep 12, 2018
Address correspondence to Paul L. Aronson, MD, Section of Pediatric Emergency Medicine, Department of Pediatrics, Yale School of Medicine, Yale University, 100
York St, Suite 1F, New Haven, CT 06511. E-mail: paul.aronson@yale.edu
PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275).
Copyright © 2018 by the American Academy of Pediatrics
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.
FUNDING: Supported, in part, by Clinical and Translational Science Awards grants KL2 TR001862 (to Drs Aronson and Shapiro) and UL1TR0001863 (to Dr Shapiro)
from the National Center for Advancing Translational Science, a component of the National Institutes of Health. The content is solely the responsibility of the
authors and does not represent the official views of the National Institutes of Health. Funded by the National Institutes of Health (NIH).
POTENTIAL CONFLICT OF INTEREST: Dr Shapiro has served as an expert witness in malpractice cases involving the evaluation of febrile children; the other
authors have indicated they have no potential conflicts of interest to disclose.
COMPANION PAPER: A companion to this article can be found online at www.pediatrics.org/cgi/doi/10.1542/peds.2018-2861.

REFERENCES
1.	Huppler AR, Eickhoff JC, Wald ER.
Performance of low-risk criteria in the
evaluation of young infants with fever:
review of the literature. Pediatrics.
2010;125(2):228–233

8

4.	Hui C, Neto G, Tsertsvadze A, et al.
Diagnosis and management of febrile
infants (0-3 months). Evid Rep Technol
Assess (Full Rep). 2012;(205):1–297

2.	Dagan R, Powell KR, Hall CB, Menegus
MA. Identification of infants unlikely
to have serious bacterial infection
although hospitalized for suspected
sepsis. J Pediatr. 1985;107(6):855–860

5.	Meehan WP III, Fleegler E, Bachur RG.
Adherence to guidelines for managing
the well-appearing febrile infant:
assessment using a case-based,
interactive survey. Pediatr Emerg Care.
2010;26(12):875–880

3.	Baker MD, Bell LM, Avner JR. Outpatient
management without antibiotics of
fever in selected infants. N Engl J Med.
1993;329(20):1437–1441

6.	Powell EC, Mahajan PV, Roosevelt G,
et al; Febrile Infant Working Group
of the Pediatric Emergency Care
Applied Research Network (PECARN).

Epidemiology of bacteremia in febrile
infants aged 60 days and younger. Ann
Emerg Med. 2018;71(2):211–216
7.	Woll C, Neuman MI, Pruitt CM,
et al; Febrile Young Infant Research
Collaborative. Epidemiology and
etiology of invasive bacterial infection
in infants ≤60 days old treated in
emergency departments. J Pediatr.
2018;200:210–217.e1
8.	Garra G, Cunningham SJ, Crain EF.
Reappraisal of criteria used to predict
serious bacterial illness in febrile

Downloaded from www.aappublications.org/news by guest on January 21, 2020

ARONSON et al

infants less than 8 weeks of age. Acad
Emerg Med. 2005;12(10):921–925
9.	Scarfone R, Murray A, Gala P, Balamuth
F. Lumbar puncture for all febrile
infants 29-56 days old: a retrospective
cohort reassessment study. J Pediatr.
2017;187:200–205.e1
10.	Chua KP, Neuman MI, McWilliams
JM, Aronson PL; Febrile Young
Infant Research Collaborative.
Association between clinical
outcomes and hospital guidelines for
cerebrospinal fluid testing in febrile
infants aged 29-56 days. J Pediatr.
2015;167(6):1340–1346.e9
11.	Aronson PL, McCulloh RJ, Tieder JS,
et al; Febrile Young Infant Research
Collaborative. Application of the
Rochester criteria to identify febrile
infants with bacteremia and meningitis
[published online ahead of print
February 5, 2018]. Pediatr Emerg Care.
doi:10.1097/PEC.0000000000001421
12.	Aronson PL, Thurm C, Alpern ER,
et al; Febrile Young Infant Research
Collaborative. Variation in care of the
febrile young infant <90 days in US
pediatric emergency departments
[published correction appears
in Pediatrics. 2015;135(4):775].
Pediatrics. 2014;134(4):667–677
13.	Aronson PL, Thurm C, Williams DJ,
et al; Febrile Young Infant Research
Collaborative. Association of clinical
practice guidelines with emergency
department management of febrile
infants ≤56 days of age. J Hosp Med.
2015;10(6):358–365
14.	Biondi E, Evans R, Mischler M, et al.
Epidemiology of bacteremia in febrile
infants in the United States. Pediatrics.
2013;132(6):990–996

17.	Baskin MN, Goh XL, Heeney MM, Harper
MB. Bacteremia risk and outpatient
management of febrile patients
with sickle cell disease. Pediatrics.
2013;131(6):1035–1041

25.	Lebel MH, McCracken GH Jr. Delayed
cerebrospinal fluid sterilization
and adverse outcome of bacterial
meningitis in infants and children.
Pediatrics. 1989;83(2):161–167

18.	Feudtner C, Hays RM, Haynes G, Geyer
JR, Neff JM, Koepsell TD. Deaths
attributed to pediatric complex
chronic conditions: national trends
and implications for supportive care
services. Pediatrics. 2001;107(6).
Available at: www.pediatrics.org/cgi/
content/full/107/6/e99

26.	Okike IO, Johnson AP, Henderson KL,
et al; neoMen Study Group. Incidence,
etiology, and outcome of bacterial
meningitis in infants aged <90 days
in the United Kingdom and Republic
of Ireland: prospective, enhanced,
national population-based surveillance.
Clin Infect Dis. 2014;59(10):e150–e157

19.	Feudtner C, Feinstein JA, Zhong W,
Hall M, Dai D. Pediatric complex
chronic conditions classification
system version 2: updated for ICD10 and complex medical technology
dependence and transplantation. BMC
Pediatr. 2014;14:199

27.	Pingree EW, Kimia AA, Nigrovic LE. The
effect of traumatic lumbar puncture on
hospitalization rate for febrile infants
28 to 60 days of age. Acad Emerg Med.
2015;22(2):240–243

20.	Tzimenatos L, Mahajan P, Dayan
PS, et al; Pediatric Emergency Care
Applied Research Network (PECARN).
Accuracy of the urinalysis for urinary
tract infections in febrile infants
60 days and younger. Pediatrics.
2018;141(2):e20173068
21.	Schroeder AR, Newman TB, Wasserman
RC, Finch SA, Pantell RH. Choice of
urine collection methods for the
diagnosis of urinary tract infection
in young, febrile infants. Arch Pediatr
Adolesc Med. 2005;159(10):915–922
22.	Harris PA, Taylor R, Thielke R, Payne
J, Gonzalez N, Conde JG. Research
electronic data capture (REDCap)–a
metadata-driven methodology and
workflow process for providing
translational research informatics
support. J Biomed Inform.
2009;42(2):377–381

15.	Leazer R, Erickson N, Paulson J,
et al. Epidemiology of cerebrospinal
fluid cultures and time to detection
in term infants. Pediatrics.
2017;139(5):e20163268

23.	Jaskiewicz JA, McCarthy CA,
Richardson AC, et al; Febrile Infant
Collaborative Study Group. Febrile
infants at low risk for serious
bacterial infection–an appraisal of the
Rochester criteria and implications
for management. Pediatrics.
1994;94(3):390–396

16.	Kestenbaum LA, Ebberson J, Zorc
JJ, Hodinka RL, Shah SS. Defining
cerebrospinal fluid white blood cell
count reference values in neonates
and young infants. Pediatrics.
2010;125(2):257–264

24.	Guarner J, Atuan MA, Nix B, et al.
Process to evaluate hematological
parameters that reflex to manual
differential cell counts in a
pediatric institution. Clin Lab.
2010;56(1–2):21–27

28.	Paxton RD, Byington CL. An examination
of the unintended consequences of the
rule-out sepsis evaluation: a parental
perspective. Clin Pediatr (Phila).
2001;40(2):71–77
29.	Long SS, Pool TE, Vodzak J, Daskalaki
I, Gould JM. Herpes simplex virus
infection in young infants during 2
decades of empiric acyclovir therapy.
Pediatr Infect Dis J. 2011;30(7):556–561
30.	Cruz AT, Freedman SB, Kulik DM, et
al; HSV Study Group of the Pediatric
Emergency Medicine Collaborative
Research Committee. Herpes simplex
virus infection in infants undergoing
meningitis evaluation. Pediatrics.
2018;141(2):e20171688
31.	Kimberlin DW, Lin CY, Jacobs RF,
et al; National Institute of Allergy and
Infectious Diseases Collaborative
Antiviral Study Group. Natural
history of neonatal herpes simplex
virus infections in the acyclovir era.
Pediatrics. 2001;108(2):223–229
32.	Gomez B, Mintegi S, Bressan S, Da Dalt
L, Gervaix A, Lacroix L; European Group
for Validation of the Step-by-Step
Approach. Validation of the “Step-byStep” approach in the management
of young febrile infants. Pediatrics.
2016;138(2):e20154381
33.	Mintegi S, Gomez B, MartinezVirumbrales L, Morientes O,
Benito J. Outpatient management
of selected young febrile infants
without antibiotics. Arch Dis Child.
2017;102(3):244–249

Downloaded from www.aappublications.org/news by guest on January 21, 2020
PEDIATRICS Volume 142, number 6, December 2018

9

Risk Stratification of Febrile Infants ≤60 Days Old Without Routine Lumbar
Puncture
Paul L. Aronson, Marie E. Wang, Eugene D. Shapiro, Samir S. Shah, Adrienne G.
DePorre, Russell J. McCulloh, Christopher M. Pruitt, Sanyukta Desai, Lise E.
Nigrovic, Richard D. Marble, Rianna C. Leazer, Sahar N. Rooholamini, Laura F.
Sartori, Fran Balamuth, Christopher Woll, Mark I. Neuman and for the Febrile Young
Infant Research Collaborative
Pediatrics 2018;142;
DOI: 10.1542/peds.2018-1879 originally published online November 13, 2018;

Updated Information &
Services

including high resolution figures, can be found at:
http://pediatrics.aappublications.org/content/142/6/e20181879

References

This article cites 33 articles, 14 of which you can access for free at:
http://pediatrics.aappublications.org/content/142/6/e20181879#BIBL

Subspecialty Collections

This article, along with others on similar topics, appears in the
following collection(s):
Emergency Medicine
http://www.aappublications.org/cgi/collection/emergency_medicine_
sub
Hospital Medicine
http://www.aappublications.org/cgi/collection/hospital_medicine_sub

Permissions & Licensing

Information about reproducing this article in parts (figures, tables) or
in its entirety can be found online at:
http://www.aappublications.org/site/misc/Permissions.xhtml

Reprints

Information about ordering reprints can be found online:
http://www.aappublications.org/site/misc/reprints.xhtml

Downloaded from www.aappublications.org/news by guest on January 21, 2020

Risk Stratification of Febrile Infants ≤60 Days Old Without Routine Lumbar
Puncture
Paul L. Aronson, Marie E. Wang, Eugene D. Shapiro, Samir S. Shah, Adrienne G.
DePorre, Russell J. McCulloh, Christopher M. Pruitt, Sanyukta Desai, Lise E.
Nigrovic, Richard D. Marble, Rianna C. Leazer, Sahar N. Rooholamini, Laura F.
Sartori, Fran Balamuth, Christopher Woll, Mark I. Neuman and for the Febrile Young
Infant Research Collaborative
Pediatrics 2018;142;
DOI: 10.1542/peds.2018-1879 originally published online November 13, 2018;

The online version of this article, along with updated information and services, is
located on the World Wide Web at:
http://pediatrics.aappublications.org/content/142/6/e20181879

Pediatrics is the official journal of the American Academy of Pediatrics. A monthly publication, it
has been published continuously since 1948. Pediatrics is owned, published, and trademarked by
the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk Grove Village, Illinois,
60007. Copyright © 2018 by the American Academy of Pediatrics. All rights reserved. Print ISSN:
1073-0397.

Downloaded from www.aappublications.org/news by guest on January 21, 2020

